ADELAIDE SMITH: Open Payments
NPI 1174927370 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 70 payments from 18 companies in 2025. Trend: 2023 $1,486 · 2024 $1,230 · 2025 $1,840
Food & beverage: $1,792Education: $48
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $558 |
| ABBVIE INC. | 15 | $359 |
| Botanix SB Inc | 5 | $176 |
| Incyte Corporation | 9 | $148 |
| GENZYME CORPORATION | 3 | $111 |
| Amgen Inc. | 4 | $95 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Lilly USA, LLC | 2 | $46 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
Products named: TREMFYA, RINVOQ, SOFDRA, SKYRIZI, OPZELURA, DUPIXENT, Otezla, Cabtreo.
Industry payments across FL — which companies pay providers there.
